Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 42.00 | |
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 112.00 | |
25 mg | In stock | $ 255.00 | |
50 mg | In stock | $ 436.00 | |
100 mg | In stock | $ 647.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 133.00 |
Description | GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM. |
Targets&IC50 | NOX2:40 μM, NOX4:5 μ M |
In vitro | In long-term experiments (1-3 days), high-glucose-induced human islet cell reactive oxygen species (ROS) production and death were prevented by GLX351322. |
Molecular Weight | 431.51 |
Formula | C21H25N3O5S |
CAS No. | 835598-94-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (46.35 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GLX351322 835598-94-2 Immunology/Inflammation Metabolism NADPH-oxidase NADPH GLX 351322 NADPH Oxidase GLX-351322 NOX Inhibitor inhibit inhibitor